Skip to main content
Petri Dish

101 College Street Rendering
101 College St. Rendering

100 College Street was the first of two towers slated for the developable land created by the Downtown Crossing Project. Currently, 100 College St (500,000 sq. ft.) is fully occupied by researchers from Alexion and Yale University.

Winstanley Enterprises has begun construction on the second bioscience tower at 101 College St. This is in response to the growing demand and to further connect the medical district and downtown area.

There are also other notable construction projects in the works, including 275 South Orange Street (planned construction in 2023, opening in 2025, and spanning 250,000 sq. ft.), Parcel B at Downtown Crossing (with an available site of 200-500,000 sq. ft.), and Science Park (with an available site of 200,000 sq. ft.).


2nd Largest Bioscience Hub in New England

The colleges and universities in Greater New Haven are dedicated to creating a globally competitive workforce while retaining the incredible talent that resides in our area. Through inclusive enrollment, relevant curricula, and community-building initiatives, we strive to empower individuals to reach their full potential and contribute to our thriving economy.

Our region is a hub for life sciences thanks to the presence of prestigious research institutions, academic centers, and a highly skilled workforce. Yale University, in particular, plays a critical role as a leading research institution and has contributed significantly to the region's reputation as a center for scientific advancements.

Greater New Haven is renowned for its world-class research institutions, including Yale School of Medicine and Yale School of Engineering. Through cutting-edge research, these institutions create new knowledge, technologies, and intellectual property that drive innovation and attract investment. The fruitful collaborations between academia and industry have led to the emergence of numerous biotechnology companies and startups that leverage research breakthroughs to develop new therapies, diagnostics, and medical devices. 

The growth of these startups creates jobs and attracts venture capital and other investments to the region. Incubators and accelerators like CTNext provide support to early-stage life science companies. These programs offer infrastructure, mentorship, funding opportunities, and networking platforms, enabling startups to develop and commercialize their innovations more efficiently. Partnerships between academia and established companies, as well as between startups and investors, contribute to the growth of the life science ecosystem.

Our region's universities and colleges play a crucial role in training a skilled workforce for the life science industry. We are honored to offer educational programs tailored to meet the industry's needs, producing graduates with scientific knowledge, research skills, and entrepreneurship acumen. Workforce development initiatives also focus on retraining and upskilling existing professionals to meet the demands of a rapidly evolving field.

Looking ahead, personalized medicine presents a significant growth opportunity for the region. The Yale Center for Genomic Health is tackling the most pressing challenge in the field: how to apply increasingly powerful genomic technologies and vast data resources to generate meaningful improvements in healthcare that will benefit people of all ancestry groups and ethnicities equitably.


BioCT: 203 470 2720